Alnylam Pharma Reports Offering of $125M in Stock
Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY), a leading RNAi therapeutics company, today announced that it has commenced an underwritten public offering of shares of its common stock to raise aggregate proceeds of approximately $125 million. All of the shares in the offering are to be sold by Alnylam.
© 2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.